|   |        |                                                                                         |
|---|--------|-----------------------------------------------------------------------------------------|
| x |   | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

|   |        |                                                                                          |
|---|--------|------------------------------------------------------------------------------------------|
| o |   | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

|                                          |        |                     |
|------------------------------------------|--------|---------------------|
| Nevada                                   |   | 91-2015186          |
| (State or other jurisdiction of          |   | (I.R.S. Employer    |
| incorporation or organization)           |   | Identification No.) |
|                                     |   |                |
| 2301 Crown Court, Irving, Texas          |   | 75038               |
| (Address of principal executive offices) |   | (Zip Code)          |

|                                   |   |                                                                                  |                                     |   |
|-----------------------------------|---|----------------------------------------------------------------------------------|-------------------------------------|---|
| Large accelerated filer | o |                                                                        | Accelerated filer              | o |
| Non-accelerated filer        | o | (Do not check if a smaller reporting company) | Smaller reporting company | x |

|                                          |        |                                 |
|------------------------------------------|--------|---------------------------------|
| Class                                    |   | Outstanding at October 29, 2010 |
| Common Stock, $0.001 par value per share |   | 21,921,934 shares               |

----

|                                      |                                                                                             |        |
|--------------------------------------|---------------------------------------------------------------------------------------------|--------|
|                                 | Page Number                                                                            |
| PART I – FINANCIAL INFORMATION |                                                                                        |
|                                 |                                                                                        |   |
| Item 1.                              | Financial Statements                                                                        | 3      |
| Item 2.                              | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 15     |
| Item 3.                              | Quantitative and Qualitative Disclosures About Market Risk                                  | 20     |
| Item 4.                              | Controls and Procedures                                                                     | 21     |
|                                 |                                                                                        |   |
| PART II – OTHER INFORMATION    |                                                                                        |
|                                 |                                                                                        |   |
| Item 1.                              | Legal Proceedings                                                                           | 22     |
| Item 1A.                             | Risk Factors                                                                                | 22     |
| Item 2.                              | Unregistered Sales of Equity Securities and Use of Proceeds                                 | 22     |
| Item 3.                              | Defaults Upon Senior Securities                                                             | 22     |
| Item 4.                              | Reserved                                                                                    | 22     |
| Item 5.                              | Other Information                                                                           | 22     |
| Item 6.                              | Exhibits                                                                                    | 22     |
|                                 |                                                                                        |   |
| Signatures                           | 23                                                                                          |
|                                 |                                                                                        |
| Exhibit Index                        | 24                                                                                          |

----

|                                                                                                                                                    |                         |            |                        |            |        |            |        |
|----------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------|------------|------------------------|------------|--------|------------|--------|
|                                                                                                                                               | September 30, 2010 |       | December 31, 2009 |
|                                                                                                                                               | (Unaudited)             |       |                   |
| ASSETS                                                                                                                                             |                    |       |                   |
| Current assets:                                                                                                                                    |                    |       |                   |
| Cash and cash equivalents                                                                                                                          | $                       | 4,813,841  |                   |       | $      | 3,972,111  |   |
| Accounts receivable, net                                                                                                                           | 513,812                 |       |                   | 576,125    |   |
| Inventories                                                                                                                                        | 5,235,756               |       |                   | 5,344,259  |   |
| Deferred income taxes                                                                                                                              | 420,292                 |       |                   | 449,254    |   |
| Prepaid expenses                                                                                                                                   | 742,658                 |       |                   | 888,303    |   |
| Total current assets                                                                                                                               | 11,726,359              |       |                   | 11,230,052 |   |
| Property and equipment, net                                                                                                                        | 4,759,406               |       |                   | 5,037,890  |   |
| Goodwill, net                                                                                                                                      | 2,280,389               |       |                   | 2,271,977  |   |
| Intangible assets, net                                                                                                                             | 57,340                  |       |                   | 61,808     |   |
| Other assets                                                                                                                                       | 13,672                  |       |                   | 10,897     |   |
|                                                                                                                                               | $                       | 18,837,166 |                   |       | $      | 18,612,624 |   |
| LIABILITIES AND SHAREHOLDERS’ EQUITY                                                                                                         |                    |       |                   |       |   |
| Current liabilities:                                                                                                                               |                    |       |                   |       |   |
| Accounts payable, trade                                                                                                                            | $                       | 1,511,680  |                   |       | $      | 1,803,997  |   |
| Accrued liabilities                                                                                                                                | 1,026,143               |       |                   | 925,060    |   |
| Current maturities of long-term obligations                                                                                                        | 165,299                 |       |                   | 155,994    |   |
| Deferred revenue                                                                                                                                   | 3,646,790               |       |                   | 3,668,907  |   |
| Total current liabilities                                                                                                                          | 6,349,912               |       |                   | 6,553,958  |   |
| Long-term obligations, less current maturities                                                                                                     | 1,770,914               |       |                   | 1,896,077  |   |
| Deferred income taxes                                                                                                                              | 946,174                 |       |                   | 943,235    |   |
| Shareholders’ equity:                                                                                                                        |                    |       |                   |       |   |
| Common stock, $0.001 par value; 50,000,000 shares authorized; 21,921,934 shares issued and outstanding at September 30, 2010 and December 31, 2009 | 21,922                  |       |                   | 21,922     |   |
| Additional paid-in capital                                                                                                                         | 13,539,666              |       |                   | 13,504,874 |   |
| Accumulated deficit                                                                                                                                | (3,922,474              | )          |                   | (4,439,094 | )      |
| Accumulated other comprehensive income                                                                                                             | 131,052                 |       |                   | 131,652    |   |
|                                                                                                                                               | 9,770,166               |       |                   | 9,219,354  |   |
|                                                                                                                                               | $                       | 18,837,166 |                   |       | $      | 18,612,624 |   |

----

|                                      |                                                               |           |        |           |        |           |        |
|--------------------------------------|---------------------------------------------------------------|-----------|--------|-----------|--------|-----------|--------|
|                                 | For the Quarters Ended September 30, |
|                                 | 2010                                                          |      | 2009   |
| Net sales                            | $                                                             | 6,126,488 |   |      | $      | 6,487,110 |   |
| Cost of sales                        | 2,836,499                                                     |      |   | 3,272,153 |   |
| Gross profit                         | 3,289,989                                                     |      |   | 3,214,957 |   |
| Operating expenses:                  |                                                          |      |   |      |   |
| General and administrative           | 2,240,966                                                     |      |   | 2,645,550 |   |
| Distributor commissions              | 758,509                                                       |      |   | 637,389   |   |
| Depreciation and amortization        | 119,422                                                       |      |   | 86,441    |   |
| Total operating expenses             | 3,118,897                                                     |      |   | 3,369,380 |   |
| Operating profit (loss)              | 171,092                                                       |      |   | (154,423  | )      |
| Interest expense                     | 37,769                                                        |      |   | 40,715    |   |
| Earnings (loss) before income taxes  | 133,323                                                       |      |   | (195,138  | )      |
| Provision (benefit) for income taxes | —                                                       |      |   | (43,000   | )      |
| Net earnings (loss)                  | $                                                             | 133,323   |   |      | $      | (152,138  | )      |

|                            |        |        |        |        |   |       |   |
|----------------------------|--------|--------|--------|--------|---|-------|---|
| Earnings (loss) per share: |   |   |   |
|   Basic          | $      | 0.01   |   |   | $ | (0.01 | ) |
|   Diluted        | 0.01   |   |   | (0.01  | ) |

|                                             |            |        |        |            |        |
|---------------------------------------------|------------|--------|--------|------------|--------|
| Weighted average common shares outstanding: |       |   |   |
|   Basic                           | 21,921,934 |   |   | 21,921,934 |   |
|   Diluted                         | 22,468,717 |   |   | 21,921,934 |   |

----

|                               |                                                                       |            |        |           |        |            |        |
|-------------------------------|-----------------------------------------------------------------------|------------|--------|-----------|--------|------------|--------|
|                          | For the Nine Months Ended September 30, |
|                          | 2010                                                                  |       | 2009   |
| Net sales                     | $                                                                     | 20,946,381 |   |      | $      | 19,262,207 |   |
| Cost of sales                 | 10,611,715                                                            |       |   | 9,386,910 |   |
| Gross profit                  | 10,334,666                                                            |       |   | 9,875,297 |   |
| Operating expenses:           |                                                                  |       |   |      |   |
| General and administrative    | 6,998,293                                                             |       |   | 7,567,442 |   |
| Distributor commissions       | 2,045,747                                                             |       |   | 1,839,814 |   |
| Depreciation and amortization | 362,339                                                               |       |   | 275,724   |   |
| Total operating expenses      | 9,406,379                                                             |       |   | 9,682,980 |   |
| Operating profit              | 928,287                                                               |       |   | 192,317   |   |
| Interest expense              | 115,567                                                               |       |   | 124,236   |   |
| Earnings before income taxes  | 812,720                                                               |       |   | 68,081    |   |
| Provision for income taxes    | 296,100                                                               |       |   | 114,000   |   |
| Net earnings (loss)           | $                                                                     | 516,620    |   |      | $      | (45,919    | )      |

|                            |        |        |        |        |   |       |   |
|----------------------------|--------|--------|--------|--------|---|-------|---|
| Earnings (loss) per share: |   |   |   |
|   Basic          | $      | 0.02   |   |   | $ | (0.00 | ) |
|   Diluted        | 0.02   |   |   | (0.00  | ) |

|                                             |            |        |        |            |        |
|---------------------------------------------|------------|--------|--------|------------|--------|
| Weighted average common shares outstanding: |       |   |   |
|   Basic                           | 21,921,934 |   |   | 21,920,394 |   |
|   Diluted                         | 22,386,287 |   |   | 21,920,394 |   |

----

|                                                      |                                                                       |           |        |            |        |           |        |
|------------------------------------------------------|-----------------------------------------------------------------------|-----------|--------|------------|--------|-----------|--------|
|                                                 | For the Nine Months Ended September 30, |
|                                                 | 2010                                                                  |      | 2009   |
| Cash flows from operating activities:                |                                                                  |      |   |
| Net earnings (loss)                                  | $                                                                     | 516,620   |   |       | $      | (45,919   | )      |
| Adjustment for non-cash items:                       |                                                                  |      |   |
| Depreciation and amortization                        | 408,957                                                               |      |   | 317,091    |   |
| Stock-based compensation                             | 34,791                                                                |      |   | 102,039    |   |
| Deferred income taxes                                | 32,842                                                                |      |   | 101,493    |   |
| Loss on disposition of equipment                     | 22,874                                                                |      |   | —    |   |
| Change in operating assets and liabilities:          |                                                                  |      |   |
| Accounts receivable                                  | 62,321                                                                |      |   | 144,281    |   |
| Inventories                                          | 110,689                                                               |      |   | 838,697    |   |
| Prepaid expenses                                     | 147,020                                                               |      |   | (58,006    | )      |
| Other assets                                         | (2,595                                                                | )         |   | —    |   |
| Accounts payable and accrued liabilities             | (192,712                                                              | )         |   | (495,464   | )      |
| Deferred revenue                                     | (22,144                                                               | )         |   | (1,439,025 | )      |
| Net cash provided by (used in) operating activities  | 1,118,663                                                             |      |   | (534,813   | )      |
| Cash flows from investing activities:                |                                                                  |      |   |       |   |
| Purchase of property and equipment                   | (155,768                                                              | )         |   | (948,943   | )      |
| Proceeds from surrender of insurance policy          | —                                                               |      |   | 194,277    |   |
| Proceeds from sale of equipment                      | 7,034                                                                 |      |   | —    |   |
| Net cash used in investing activities                | (148,734                                                              | )         |   | (754,666   | )      |
| Cash flows from financing activities:                |                                                                  |      |   |       |   |
| Payments of long-term obligations                    | (115,858                                                              | )         |   | (107,245   | )      |
| Proceeds from the exercise of stock options          | —                                                               |      |   | 1,455      |   |
| Net cash used in financing activities                | (115,858                                                              | )         |   | (105,790   | )      |
| Effect of exchange rate changes on cash flows        | (12,341                                                               | )         |   | (60,181    | )      |
| Net increase (decrease) in cash and cash equivalents | 841,730                                                               |      |   | (1,455,450 | )      |
| Cash and cash equivalents, beginning of period       | 3,972,111                                                             |      |   | 4,973,405  |   |
| Cash and cash equivalents, end of period             | $                                                                     | 4,813,841 |   |       | $      | 3,517,955 |   |

----

----

|                                 |                         |           |                        |           |        |           |        |
|---------------------------------|-------------------------|-----------|------------------------|-----------|--------|-----------|--------|
|                            | September 30, 2010 |      | December 31, 2009 |
| Raw materials and bulk products | $                       | 476,938   |                   |      | $      | 403,616   |   |
| Packaging materials             | 341,163                 |      |                   | 488,545   |   |
| Finished goods                  | 4,417,655               |      |                   | 4,452,098 |   |
|                            | $                       | 5,235,756 |                   |      | $      | 5,344,259 |   |

|                                      |                         |         |                        |         |        |         |        |
|--------------------------------------|-------------------------|---------|------------------------|---------|--------|---------|--------|
|                                 | September 30, 2010 |    | December 31, 2009 |
| Advance payment to suppliers         | $                       | 233,467 |                   |    | $      | 177,415 |   |
| Prepaid income taxes                 | 196,423                 |    |                   | 453,177 |   |
| Certificates of deposit - restricted | 82,578                  |    |                   | 81,252  |   |
| Prepaid insurance and other          | 230,190                 |    |                   | 176,459 |   |
|                                 | $                       | 742,658 |                   |    | $      | 888,303 |   |

|                                        |                         |           |                        |            |        |           |        |
|----------------------------------------|-------------------------|-----------|------------------------|------------|--------|-----------|--------|
|                                   | September 30, 2010 |      | December 31, 2009 |
| Building and improvements              | $                       | 3,523,428 |                   |       | $      | 3,523,428 |   |
| Computer software and office equipment | 2,055,988               |      |                   | 2,314,849  |   |
| Warehouse equipment                    | 219,030                 |      |                   | 286,731    |   |
| Automotive equipment                   | 15,228                  |      |                   | 15,228     |   |
| Leasehold improvements                 | —                 |      |                   | 20,894     |   |
|                                   | 5,813,674               |      |                   | 6,161,130  |   |
| Less – accumulated depreciation  | (2,195,441              | )         |                   | (2,264,413 | )      |
|                                   | 3,618,233               |      |                   | 3,896,717  |   |
| Land                                   | 1,141,173               |      |                   | 1,141,173  |   |
|                                   | $                       | 4,759,406 |                   |       | $      | 5,037,890 |   |

----

|                                 |                      |           |                          |        |   |            |   |
|---------------------------------|----------------------|-----------|--------------------------|--------|---|------------|---|
|                            | Gross Carrying Value |      | Accumulated Amortization |
| Balance, December 31, 2009      | $                    | 3,384,487 |                     |   | $ | (1,112,510 | ) |
| Currency translation adjustment | 16,414               |      |                     | (8,002 | ) |
| Balance, September 30, 2010     | $                    | 3,400,901 |                     |   | $ | (1,120,512 | ) |

|                                                |                    |        |                         |         |                         |        |                    |         |                         |        |        |         |        |        |   |         |   |
|------------------------------------------------|--------------------|--------|-------------------------|---------|-------------------------|--------|--------------------|---------|-------------------------|--------|--------|---------|--------|--------|---|---------|---|
|                                           |               |   | September 30, 2010 |    | December 31, 2009  |
|                                           | AverageLife(years) |   | GrossCarryingValue      |    | AccumulatedAmortization |   | GrossCarryingValue |    | AccumulatedAmortization |
| Copyrights, trademarks and other registrations | 19                 |   | $                       | 99,100  |                    |   | $                  | (48,228 | )                       |   | $      | 99,100  |   |   | $ | (44,264 | ) |
| Other                                          | 19                 |   | 12,600                  |    |                    | (6,132 | )                  |    | 12,600                  |   |   | (5,628  | )      |
|                                           |               |   | $                       | 111,700 |                    |   | $                  | (54,360 | )                       |   | $      | 111,700 |   |   | $ | (49,892 | ) |

|                   |        |        |        |
|-------------------|--------|--------|--------|
| Remainder of 2010 | $      | 1,489  |   |
| 2011              | 5,957  |   |
| 2012              | 5,957  |   |
| 2013              | 5,957  |   |
| 2014              | 5,957  |   |
| Thereafter        | 32,023 |   |
| Total             | $      | 57,340 |   |

|                          |                         |           |                        |         |        |         |        |
|--------------------------|-------------------------|-----------|------------------------|---------|--------|---------|--------|
|                     | September 30, 2010 |      | December 31, 2009 |
| Salaries and wages       | $                       | 394,065   |                   |    | $      | 436,916 |   |
| Distributor commissions  | 446,316                 |      |                   | 317,562 |   |
| Sales and property taxes | 64,540                  |      |                   | 40,684  |   |
| Interest                 | 12,505                  |      |                   | 13,253  |   |
| Other                    | 108,717                 |      |                   | 116,645 |   |
|                     | $                       | 1,026,143 |                   |    | $      | 925,060 |   |

----

|                                        |                                             |        |                                 |         |        |        |         |        |        |         |        |
|----------------------------------------|---------------------------------------------|--------|---------------------------------|---------|--------|--------|---------|--------|--------|---------|--------|
|                                   | Quarters Ended September 30, |   | Nine Months Ended September 30, |
|                                   | 2010                                        |   | 2009                            |    | 2010   |   | 2009    |
|                                   |                                        |   | (1)                             |    |   |   |    |
| Weighted average expected life (years) | 9.0                                         |   |                            | — |   |   | 9.0     |   |   | 7.3     |   |
| Risk-free interest rate                | 3.09                                        | %      |                            | — | %      |   | 3.09    | %      |   | 2.67    | %      |
| Expected volatility                    | 105.02                                      | %      |                            | — | %      |   | 105.02  | %      |   | 114.92  | %      |
| Expected dividend yield                | —                                     | %      |                            | — | %      |   | — | %      |   | — | %      |

|                                   |           |        |                                           |         |                                                             |        |                           |                                                                                                                                                                                                                                      |        |        |   |         |        |
|-----------------------------------|-----------|--------|-------------------------------------------|---------|-------------------------------------------------------------|--------|---------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|---|---------|--------|
|                              | Options   |   | Weighted-Average Exercise Price per Share |    | Weighted-Average Remaining Contractual Term (in years) |   | Aggregate Intrinsic Value |
| Outstanding on January 1, 2010    | 2,130,440 |   |                                      | $       | 0.40                                                        |   |                      |                                        |   |   |
| Granted                           | 25,000    |   |                                      | 0.36    |                                                        |   |                      |                                                                                                                                                                                                                                 |   |
| Exercised                         | —   |   |                                      | — |                                                        |   |                      |                                                                                                                                                                                                                                 |   |
| Forfeited/canceled                | (616,267  | )      |                                      | 0.64    |                                                        |   |                      |                                                                                                                                                                                                                                 |   |
| Outstanding on September 30, 2010 | 1,539,173 |   |                                      | $       | 0.31                                                        |   |                      | 3.3                                                                                                                                                                                                                                  |   |   | $ | 214,752 |   |
| Exercisable on September 30, 2010 | 1,125,360 |   |                                      | $       | 0.23                                                        |   |                      | 2.4                                                                                                                                                                                                                                  |   |   | $ | 206,518 |   |

|                                                |          |        |                                                  |      |        |        |
|------------------------------------------------|----------|--------|--------------------------------------------------|------|--------|--------|
|                                           | Shares   |   | Weighted-Average Grant Date Fair Value per Share |
| Non-vested stock options at January 1, 2010    | 871,750  |   |                                             | $    | 0.55   |   |
| Non-vested stock options granted               | 25,000   |   |                                             | 0.32 |   |
| Vested stock options                           | (70,000  | )      |                                             | 0.56 |   |
| Forfeited stock options                        | (412,937 | )      |                                             | 0.61 |   |
| Non-vested stock options at September 30, 2010 | 413,813  |   |                                             | 0.47 |   |

----

|                                                                                                                                                                                                                                                         |                         |           |                        |          |   |           |        |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------|-----------|------------------------|----------|---|-----------|--------|
|                                                                                                                                                                                                                                                    | September 30, 2010 |      | December 31, 2009 |
| Mortgage note payable bearing interest at 7.75%, payable in monthly installments of $25,797 through April 2019, collateralized by land and building, and personally guaranteed by the Company’s Chairman of the Board and Chief Executive Officer | $                       | 1,936,213 |                   |     | $ | 2,052,071 |   |
| Less – current maturities                                                                                                                                                                                                                         | (165,299                | )         |                   | (155,994 | ) |
|                                                                                                                                                                                                                                                    | $                       | 1,770,914 |                   |     | $ | 1,896,077 |   |

----

|                                                               |                           |        |                       |         |              |        |        |        |   |        |        |
|---------------------------------------------------------------|---------------------------|--------|-----------------------|---------|--------------|--------|--------|--------|---|--------|--------|
|                                                          | Nutritional Products |   | Medical Products |    | Consolidated |
| Quarter Ended September 30, 2010          |                      |   |                  |    |         |
| Net sales                                                     | $                         | 4,533  |                  |    | $            | 1,593  |   |   | $ | 6,126  |   |
| Depreciation and amortization                                 | 114                       |   |                  | 21      |         |   | 135    |   |
| Operating profit                                              | 85                        |   |                  | 86      |         |   | 171    |   |
| Capital expenditures                                          | 23                        |   |                  | — |         |   | 23     |   |
| Total assets                                                  | 15,657                    |   |                  | 3,180   |         |   | 18,837 |   |
| Quarter Ended September 30, 2009          |                      |   |                  |    |         |   |   |   |
| Net sales                                                     | $                         | 4,982  |                  |    | $            | 1,505  |   |   | $ | 6,487  |   |
| Depreciation and amortization                                 | 101                       |   |                  | 11      |         |   | 112    |   |
| Operating profit (loss)                                       | (214                      | )      |                  | 60      |         |   | (154   | )      |
| Capital expenditures                                          | 183                       |   |                  | 12      |         |   | 195    |   |
| Total assets                                                  | 15,065                    |   |                  | 2,813   |         |   | 17,878 |   |
| Nine Months Ended September 30, 2010 |                      |   |                  |    |         |   |   |   |
| Net sales                                                     | $                         | 16,134 |                  |    | $            | 4,812  |   |   | $ | 20,946 |   |
| Depreciation and amortization                                 | 346                       |   |                  | 63      |         |   | 409    |   |
| Operating profit                                              | 668                       |   |                  | 260     |         |   | 928    |   |
| Capital expenditures                                          | 156                       |   |                  | — |         |   | 156    |   |
| Total assets                                                  | 15,657                    |   |                  | 3,180   |         |   | 18,837 |   |
| Nine Months Ended September 30, 2009 |                      |   |                  |    |         |   |   |   |
| Net sales                                                     | $                         | 14,803 |                  |    | $            | 4,459  |   |   | $ | 19,262 |   |
| Depreciation and amortization                                 | 267                       |   |                  | 50      |         |   | 317    |   |
| Operating profit                                              | 12                        |   |                  | 180     |         |   | 192    |   |
| Capital expenditures                                          | 930                       |   |                  | 19      |         |   | 949    |   |
| Total assets                                                  | 15,065                    |   |                  | 2,813   |         |   | 17,878 |   |

|                       |                                                      |        |                                                      |         |                |        |                        |        |        |         |        |        |   |       |        |
|-----------------------|------------------------------------------------------|--------|------------------------------------------------------|---------|----------------|--------|------------------------|--------|--------|---------|--------|--------|---|-------|--------|
|                  | Quarter Ended September 30, 2010 |   | Quarter Ended September 30, 2009 |
|                  | Net sales                                       |   | Long-Lived assets                               |    | Net sales |   | Long-Lived assets |
| Domestic              | $                                                    | 2,518  |                                                 |    | $              | 6,575  |                   |   | $      | 2,804   |   |   | $ | 6,806 |   |
| Russia/Eastern Europe | 2,965                                                |   |                                                 | — |           |   | 3,398                  |   |   | — |   |
| Canada                | 249                                                  |   |                                                 | 536     |           |   | 262                    |   |   | 540     |   |
| All others            | 394                                                  |   |                                                 | — |           |   | 23                     |   |   | — |   |
| Totals                | $                                                    | 6,126  |                                                 |    | $              | 7,111  |                   |   | $      | 6,487   |   |   | $ | 7,346 |   |

----

|                       |                                                               |        |                                                               |         |                |        |                        |        |        |         |        |        |   |       |        |
|-----------------------|---------------------------------------------------------------|--------|---------------------------------------------------------------|---------|----------------|--------|------------------------|--------|--------|---------|--------|--------|---|-------|--------|
|                  | Nine Months Ended September 30, 2010 |   | Nine Months Ended September 30, 2009 |
|                  | Net sales                                                |   | Long-Lived assets                                        |    | Net sales |   | Long-Lived assets |
| Domestic              | $                                                             | 7,928  |                                                          |    | $              | 6,575  |                   |   | $      | 8,181   |   |   | $ | 6,806 |   |
| Russia/Eastern Europe | 11,552                                                        |   |                                                          | — |           |   | 10,004                 |   |   | — |   |
| Canada                | 808                                                           |   |                                                          | 536     |           |   | 804                    |   |   | 540     |   |
| All others            | 658                                                           |   |                                                          | — |           |   | 273                    |   |   | — |   |
| Totals                | $                                                             | 20,946 |                                                          |    | $              | 7,111  |                   |   | $      | 19,262  |   |   | $ | 7,346 |   |

|                                                               |                   |          |                       |         |                |        |        |        |       |        |
|---------------------------------------------------------------|-------------------|----------|-----------------------|---------|----------------|--------|--------|--------|-------|--------|
|                                                          | Net Earnings |     | WeightedAverageShares |    | Per Share |
| Quarter Ended September 30, 2010          |              |     |                  |    |           |
| Basic earnings per common share                               | $                 | 133,323  |                  |    | 21,921,934     |   |   | $      | 0.01  |   |
| Effect of dilutive stock options                              | —           |     |                  | 546,783 |           |   |   |   |
| Diluted earnings per common share                             | $                 | 133,323  |                  |    | 22,468,717     |   |   | $      | 0.01  |   |
| Quarter Ended September 30, 2009          |              |     |                  |    |           |   |   |   |
| Basic loss per common share                                   | $                 | (152,138 | )                     |    | 21,921,934     |   |   | $      | (0.01 | )      |
| Effect of dilutive stock options                              | —           |     |                  | — |           |   |   |   |
| Diluted loss per common share                                 | $                 | (152,138 | )                     |    | 21,921,934     |   |   | $      | (0.01 | )      |
| Nine Months Ended September 30, 2010 |              |     |                  |    |           |   |   |   |
| Basic earnings per common share                               | $                 | 516,620  |                  |    | 21,921,934     |   |   | $      | 0.02  |   |
| Effect of dilutive stock options                              | —           |     |                  | 464,353 |           |   |   |   |
| Diluted earnings per common share                             | $                 | 516,620  |                  |    | 22,386,287     |   |   | $      | 0.02  |   |
| Nine Months Ended September 30, 2009 |              |     |                  |    |           |   |   |   |
| Basic loss per common share                                   | $                 | (45,919  | )                     |    | 21,920,394     |   |   | $      | (0.00 | )      |
| Effect of dilutive stock options                              | —           |     |                  | — |           |   |   |   |
| Diluted loss per common share                                 | $                 | (45,919  | )                     |    | 21,920,394     |   |   | $      | (0.00 | )      |

----

|                                         |                                             |         |                                 |        |        |          |        |        |        |         |        |        |   |         |   |
|-----------------------------------------|---------------------------------------------|---------|---------------------------------|--------|--------|----------|--------|--------|--------|---------|--------|--------|---|---------|---|
|                                    | Quarters Ended September 30, |    | Nine Months Ended September 30, |
|                                    | 2010                                        |    | 2009                            |   | 2010   |     | 2009   |
| Net earnings (loss)                     | $                                           | 133,323 |                            |   | $      | (152,138 | )      |   | $      | 516,620 |   |   | $ | (45,919 | ) |
| Other comprehensive income:             |                                        |    |                            |   |   |     |   |   |   |    |   |
| Foreign currency translation adjustment | (2,405                                      | )       |                            | 15,150 |   |     | (600   | )      |   | 26,540  |   |
| Comprehensive income (loss)             | $                                           | 130,918 |                            |   | $      | (136,988 | )      |   | $      | 516,020 |   |   | $ | (19,379 | ) |

----

|                                 |                                                                                        |
|---------------------------------|----------------------------------------------------------------------------------------|
| ITEM 2.     | Management's Discussion and Analysis of Financial Condition and Results of Operations. |

|                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|--------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| •     | Through the Nutritional Products segment, we distribute products in three broad categories: (i) wellness products, (ii) fitness products and (iii) skin care products.   Products include herbal formulas, vitamins, minerals, antioxidants and personal care products.  In certain markets, principally in the U.S. and Canada, we distribute Nutritional Products directly through a network of independent Associates. In certain other markets, we distribute Nutritional Products through exclusive license arrangements with third parties who, for the most part, distribute our products through an independent Associate network in the licensed territory. |

|                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|--------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| •     | Through the Medical Products segment, we distribute wound care products.  These products are distributed mainly in the U.S. to hospitals, nursing homes, clinics and pharmacies through traditional medical/surgical supply dealers and pharmaceutical distributors.  Medical Products are used to prevent and treat wounds, and manage pain associated with wounds, in the acute care, long-term care and oncology markets. |

|                       |                                              |        |        |        |        |        |        |        |        |        |        |     |   |
|-----------------------|----------------------------------------------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|-----|---|
|                  | Quarters Ended September 30,  |
|                  | 2010                                         |   | 2009   |
|                  | (U.S. dollars in 000’s) |
| Nutritional Products: |                                         |   |   |   |   |   |   |
| Licensees             | $                                            | 3,005  |   |   | 49     | %      |   | $      | 3,421  |   |   | 53  | % |
| Associate network     | 1,528                                        |   |   | 25     | %      |   | 1,561  |   |   | 24     | %      |
|                  | 4,533                                        |   |   | 74     | %      |   | 4,982  |   |   | 77     | %      |
| Medical Products      | 1,593                                        |   |   | 26     | %      |   | 1,505  |   |   | 23     | %      |
|                  | $                                            | 6,126  |   |   | 100    | %      |   | $      | 6,487  |   |   | 100 | % |

----

|                       |                                              |        |        |        |        |        |        |        |        |        |        |     |   |
|-----------------------|----------------------------------------------|--------|--------|--------|--------|--------|--------|--------|--------|--------|--------|-----|---|
|                  | Nine Months Ended September 30,              |
|                  | 2010                                         |   | 2009   |
|                  | (U.S. dollars in 000’s) |
| Nutritional Products: |                                         |   |   |   |   |   |   |
| Licensees             | $                                            | 11,801 |   |   | 56     | %      |   | $      | 10,277 |   |   | 54  | % |
| Associate network     | 4,333                                        |   |   | 21     | %      |   | 4,526  |   |   | 23     | %      |
|                  | 16,134                                       |   |   | 77     | %      |   | 14,803 |   |   | 77     | %      |
| Medical Products      | 4,812                                        |   |   | 23     | %      |   | 4,459  |   |   | 23     | %      |
|                  | $                                            | 20,946 |   |   | 100    | %      |   | $      | 19,262 |   |   | 100 | % |

|               |                                             |        |                                 |         |        |        |      |        |        |         |        |
|---------------|---------------------------------------------|--------|---------------------------------|---------|--------|--------|------|--------|--------|---------|--------|
|          | Quarters Ended September 30, |   | Nine Months Ended September 30, |
|          | 2010                                        |   | 2009                            |    | 2010   |   | 2009 |
| United States | 63                                          | %      |                            | 83      | %      |   | 72   | %      |   | 82      | %      |
| Canada        | 16                                          |   |                            | 17      |   |   | 19   |   |   | 18      |   |
| Taiwan        | 21                                          |   |                            | — |   |   | 9    |   |   | — |   |
|          | 100                                         | %      |                            | 100     | %      |   | 100  | %      |   | 100     | %      |

----

|                                      |                                             |        |                                 |        |         |        |        |        |        |        |         |
|--------------------------------------|---------------------------------------------|--------|---------------------------------|--------|---------|--------|--------|--------|--------|--------|---------|
|                                 | Quarters Ended September 30, |   | Nine Months Ended September 30, |
|                                 | 2010                                        |   | 2009                            |   | 2010    |   | 2009   |
| Net sales                            | 100.0                                       | %      |                            | 100.0  |  % |   | 100.0  | %      |   | 100.0  |  % |
| Cost of sales                        | 46.3                                        |   |                            | 50.4   |    |   | 50.7   |   |   | 48.7   |    |
| Gross profit                         | 53.7                                        |   |                            | 49.6   |    |   | 49.3   |   |   | 51.3   |    |
| Operating expenses:                  |                                        |   |                            |   |    |   |   |   |   |   |    |
| General and administrative           | 36.6                                        |   |                            | 40.8   |    |   | 33.4   |   |   | 39.3   |    |
| Distributor commissions              | 12.4                                        |   |                            | 9.9    |    |   | 9.8    |   |   | 9.6    |    |
| Depreciation and amortization        | 1.9                                         |   |                            | 1.3    |    |   | 1.7    |   |   | 1.4    |    |
| Total operating expenses             | 50.9                                        |   |                            | 52.0   |    |   | 44.9   |   |   | 50.3   |    |
| Operating profit (loss)              | 2.8                                         |   |                            | (2.4   | )       |   | 4.4    |   |   | 1.0    |    |
| Interest expense                     | 0.6                                         |   |                            | 0.6    |    |   | 0.5    |   |   | 0.6    |    |
| Earnings (loss) before income taxes  | 2.2                                         |   |                            | (3.0   | )       |   | 3.9    |   |   | 0.4    |    |
| Provision (benefit) for income taxes | —                                     |   |                            | (0.7   | )       |   | 1.4    |   |   | 0.6    |    |
| Net earnings (loss)                  | 2.2                                         | %      |                            | (2.3   | )%      |   | 2.5    | %      |   | (0.2   | )%      |

----

----

----

|                                 |                                                             |
|---------------------------------|-------------------------------------------------------------|
| ITEM 3.     | Quantitative and Qualitative Disclosures About Market Risk. |

----

|                                 |                          |
|---------------------------------|--------------------------|
| ITEM 4.     | Controls and Procedures. |

----

|                                 |                    |
|---------------------------------|--------------------|
| ITEM 1.     | Legal Proceedings. |

|                                  |               |
|----------------------------------|---------------|
| ITEM 1A.     | Risk Factors. |

|                                 |                                                              |
|---------------------------------|--------------------------------------------------------------|
| ITEM 2.     | Unregistered Sales of Equity Securities and Use of Proceeds. |

|                                 |                                  |
|---------------------------------|----------------------------------|
| ITEM 3.     | Defaults Upon Senior Securities. |

|                                 |           |
|---------------------------------|-----------|
| ITEM 4.     | Reserved. |

|                                 |                    |
|---------------------------------|--------------------|
| ITEM 5.     | Other Information. |

|                                 |           |
|---------------------------------|-----------|
| ITEM 6.     | Exhibits. |

----

|                        |        |                         |                                                                                                    |
|------------------------|--------|-------------------------|----------------------------------------------------------------------------------------------------|
|                   |   | RBC Life Sciences, Inc. |
|                   |   | Registrant              |
|                   |   |                    |                                                                                               |
| November 12, 2010 |   | By:                     | /s/             Clinton H. Howard |
| Date                   |   | Its:                    | President and Chief Executive Officer                                                              |
|                   |   |                    |                                                                                               |
| November 12, 2010 |   | By:                     | /s/              Steven E. Brown  |
| Date                   |   | Its:                    | Vice President-Finance and                                                                         |
|                   |   |                    | Chief Financial Officer                                                                            |
|                   |   |                    | (Principal Financial and Accounting Officer)                                                       |

----

|                     |                                                                                                                                                       |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------|
| Exhibit Number | Description                                                                                                                                           |
| 31.1                | Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                |
|                |                                                                                                                                                  |
| 31.2                | Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                |
|                |                                                                                                                                                  |
| 32.1                | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
|                |                                                                                                                                                  |
| 32.2                | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |